Clinical and microbiological characteristics of spontaneous acute prostatitis and transrectal prostate biopsy-related acute prostatitis: Is transrectal prostate biopsy-related acute prostatitis a distinct acute prostatitis category?

Kim, Jong Wook; Oh, Mi Mi; Bae, Jae Hyun; Kang, Seok Ho; Park, Hong Seok; Moon, Du Geon

doi:10.1016/j.jiac.2015.01.014

Cited by 16 publications

(17 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In an unpublished study in which we compared the characteristics of CA-ABP and Bx-ABP during the same period, the results showed that the CA-ABP group had a higher rate of antibiotic sensitive E . coli and lower ESBL (+) rates than the Bx-ABP group, similar to the results of Kim et al [10]. Ha et al [5] also reported that the group ‘with prior manipulation' had a significantly higher Pseudomonas identification rate compared to the group ‘without prior manipulation'.…”

Section: Discussionsupporting

confidence: 84%

“…Kim et al [10] reported that spontaneous ABP showed higher E. coli antibiotic sensitivity and lower ESBL (+) rates compared to ABP after prostate biopsy (Bx-ABP). In an unpublished study in which we compared the characteristics of CA-ABP and Bx-ABP during the same period, the results showed that the CA-ABP group had a higher rate of antibiotic sensitive E .…”

Section: Discussionmentioning

confidence: 99%

“…There have been several studies on the characteristics of ABP in Korea [5,10], but precise comparisons between studies are difficult because they each divide ABP by different criteria rather than following the classifications of hospital-acquired (HA, in patients who had been hospitalized for ≥48 h), healthcare-associated (HCA, at the time of hospital admission or within 48 h of admission and when the patients had received intravenous therapy, wound care or specialized nursing care at home during the 30 days before the infection, had attended a hemodialysis clinic or received intravenous therapy in the 30 days before the infection, had been hospitalized for acute care for ≥2 days in an acute care hospital in the 90 days preceding the infection, had resided in a nursing home or long-term care facility and had undergone an invasive urinary procedure, urological surgery or urethral catheterization within the 30 days before the infection) and CA (patients who did not fit the criteria for an HA and HCA infection upon hospital admission or within the 48 h after admission) ABP as suggested by Friedman et al [11]. In addition, the bacterial identification rate at initial hospitalization for ABP in these studies was <50%, limiting the ability to determine the exact features of CA-ABP.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Clinical and Microbiological Features and Factors Associated with Fluoroquinolone Resistance in Men with Community-Acquired Acute Bacterial Prostatitis

Park

Cho²,

Cho³

et al. 2016

Urol Int

View full text Add to dashboard Cite

Objectives: To investigate the clinical and microbiological features in the patients with community-acquired acute bacterial prostatitis (CA-ABP), as well as factors that affect fluoroquinolone resistance. Methods: A retrospective analysis was performed of 209 patients hospitalized for antibiotic treatment of CA-ABP. We investigated patient age, body mass index, underlying diseases, recurrence, prostate-related factors and results of urine culture examination and antibiotic sensitivity tests. Results: Seventeen patients (8.1%) had fluoroquinolone-resistant bacterial colonies. When we divided the subjects into groups according to the fluoroquinolone resistance, the group with resistant bacteria was significantly older, had larger prostates and had greater residual urine volumes. Bacteria were identified in 127 of 209 patients (60.8%), and the most commonly cultured included Escherichia coli (43.5%). The sensitivity of the cultured bacteria to fluoroquinolones was high compared to trimethoprim/sulfamethoxazole and gentamicin, but similar to cefotaxime. The bacteria were more sensitive to amikacin and imipenem than to fluoroquinolone. The multivariate analysis revealed that prostate volume ≥40 ml (p = 0.024) and residual urine volume >100 ml (p = 0.004) were independent predictive factors for fluoroquinolone resistance. Conclusions: Fluoroquinolone monotherapy might be an effective treatment in CA-ABP. However, combination antibiotic therapy is recommended in cases with prostate volume ≥40 ml or residual urine volume >100 ml, because fluoroquinolone resistance can occur.

show abstract

Section: Discussionsupporting

confidence: 84%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Clinical and Microbiological Features and Factors Associated with Fluoroquinolone Resistance in Men with Community-Acquired Acute Bacterial Prostatitis

Park

Cho²,

Cho³

et al. 2016

Urol Int

View full text Add to dashboard Cite

show abstract

“…However, the incidence of more serious infectious complications requiring hospitalization has dramatically increased over time 2,15,[58][59][60] , with fluoroquinolone-resistant (FQR) Escherichia Coli as the most recognized risk factor 2,45,47,[49][50][51]53 . In this scenario, patients with biopsy-related bacterial acute prostatitis have a higher risk of sepsis when compared to those with spontaneous acute prostatitis, probably due to a different pathogenic bacterial strain among the two groups 61 . Furthermore, medical comorbidities (particularly diabetes or metabolic syndrome) and older age are independent predictors increasing the risk of infections and sepsis 45,58,60,62 .…”

Section: Infectious Complications and Hospitalization Rates After Promentioning

confidence: 99%

Complications After Systematic, Random, and Image-guided Prostate Biopsy

et al. 2017

View full text Add to dashboard Cite

Evidence Synthesis: The most frequent complication after PB is minor and self-limiting bleeding (hematuria and hematospermia), irrespective of the biopsy approach. Occurrence of rectal bleeding was comparable among traditional TRUS-guided and image-guided PB. Almost 25% of patients experience lower urinary tract symptoms, but only a few have urinary retention, with higher rates after transperineal approach. Temporary erectile dysfunction is not negligible, with a return to baseline after 1-6 months. The incidence of infective complications is being increasing, with higher rates among men with medical comorbidities and older age. Transperineal and in-bore MRI targeted biopsy may reduce the risk of severe infectious complications. Mortality after PB is uncommon, irrespective of biopsy technique. Conclusions:Complications after PB are frequent but often self-limiting. The incidence of hospitalization due to severe infections is continuously increasing. Still, a careful appraisal of 3 patient's general health status, risk factors and likelihood of antimicrobial resistance should be done before scheduling a PB. Patient Summary:In this paper we reviewed the variety and incidence of complications after prostate biopsy. Even if frequent, seldom represent a problem for the patient. The most troublesome complications are infections. In order to minimize this risk, a careful evaluation of patient's medical condition must be done before biopsy.4

show abstract

“…The question of the role of gram-positive bacteria, as well as nonclostridial anaerobes has been debated for several decades and still remains open [11]. A comparison of the clinical details in a series of acute bacterial prostatitis after transrectal prostate biopsy described a higher incidence of sepsis and antibioticresistant bacteria in the post biopsy prostatitis group [12]. The low detection rate of prostate biopsy is determined by the lack of specificity of PSA that causes challenging diagnostic problems for urologists, additional morbidity and anxiety for patients and higher costs for health systems.…”

Section: Introductionmentioning

confidence: 99%

Pattern of Bacterial Isolates and Antimicrobial Susceptibility of Urine Culture in Men with Chronic Bacterial Prostatitis and Levels PSA Before and After Treatment

Dv¹,

Va²,

Salam³

et al. 2017

JURNOA

View full text Add to dashboard Cite

Objective: To study the influence of combined antibiotic therapy on levels PSA in "grey zone" for patients with chronic bacterial prostatitis without signs prostate cancer. Patients and Methods:In our study was presented 125 patients in aged 30-83 years with diagnosis of chronic bacterial prostatitis. We performed digital rectal examination, urine culture, transrectal ultrasound investigation of prostate, PSA analysis before and after antibiotic treatment and antimicrobial susceptibility testing. Criteria for inclusion in the trial were digital rectal examination without suspicion of urological cancers, absence of history of intravesical instrumentation and biopsy of prostate , values PSA in range from 4,0 to 11 ng/ml, symptoms of chronic bacterial prostatitis, absence of abnormalities both upper and lower urinary tracts. For evaluation changes PSA before and after treatment we divided all patients on five groups with different regimen antimicrobial agents in according to results antibiotic susceptibility test.Results: A total of 125 patients with chronic bacterial prostatitis and high level of PSA were estimated by culture of urine for determination spectrum of isolated microorganisms and pattern susceptibility to antimicrobial agents. The average (mean ± standard deviation) age of all men in this study was 59.6 ± 12.7 years. The non-clostridial, non-spore forming anaerobic microorganisms, the taxonomic structure of chronic bacterial prostatitis were more often represented by Peptococcus spp (37,8%), Propionibacterium spp (36%), Eubacterium spp (47,2%), Veillonella spp (24,4%) with average level of bacteriuria Log 1,5 CFU/ml , Log 2,6 CFU/ml, Log 3,2 CFU/ml, Log 1,9 CFU/ml, respectively. In the group of cougulasenegative staphylococci predominated S.epidermidis (29,5%), S.haemalyticus (20,8%), S.aureus (12%) with mean level of bacteriuria Log 1,5 CFU/ ml , Log 1,9 CFU/ml, Log 1,8 CFU/ml , respectively. In five groups patients which divided in depending from chosen regimen of combined antibiotic treatment in according results susceptibility testing to antimicrobial agents, the changes of level PSA were following : in I group (25 patients) 7,34 ± 2,6 , 95% CI [6.27 -8.41] before and 2.26 ± 1.02 , 95% CI [1.84 -2.68] after treatment, administration ; in II group (22 patients) 7.20 ± 1.76 ,95% CI (6.42 -7.98) before and 1.8 ± 0.84 , 95% CI (1.43 -2.17) after; in III groups (26 patients) 7.05 ± 1.35, 95% CI (6.5 -7.6) before and 1.57 ± 0.89 , 95% CI (1.21 -1.93) after treatment ; in IV group (24 patients) 7.51 ± 1.39 ,95% CI (6.92 -8.1) before and 1.45 ± 0.93 , 95% CI (1.29 -1.61) after treatment ; in V group (28 patients) 7.11 ± 1.16, 95% CI (6.66 -7.56) before and 1.48 ± 0.86 95% CI (1.15 -1.81) after treatment . After 3 and 6 months we performed the repeat measurement of level PSA and there was no any elevation higher than > 4 ng/ ml. Conclusions:In patients with baseline level PSA in range 4-10 ng/ml provided that possibility of PCa is excluded by digital rectal examination and transrectal ultrasound inv...

show abstract

Clinical and microbiological characteristics of spontaneous acute prostatitis and transrectal prostate biopsy-related acute prostatitis: Is transrectal prostate biopsy-related acute prostatitis a distinct acute prostatitis category?

Cited by 16 publications

References 24 publications

Clinical and Microbiological Features and Factors Associated with Fluoroquinolone Resistance in Men with Community-Acquired Acute Bacterial Prostatitis

Clinical and Microbiological Features and Factors Associated with Fluoroquinolone Resistance in Men with Community-Acquired Acute Bacterial Prostatitis

Complications After Systematic, Random, and Image-guided Prostate Biopsy

Pattern of Bacterial Isolates and Antimicrobial Susceptibility of Urine Culture in Men with Chronic Bacterial Prostatitis and Levels PSA Before and After Treatment

Contact Info

Product

Resources

About